Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02479438 · ClinicalTrials.gov registry record
Gastroesophageal Reflux Disease Prospective Registry
A clinical trial, sponsored by Baylor Research Institute.
- Terminated
- Registry status
- 744
- Enrollment target
NCT02479438: Clinical Trial study, sponsored by Baylor Research Institute.
NCT02479438 is a clinical trial that was terminated before completion, run by Baylor Research Institute. The registered enrollment target is 744 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02479438 was terminated before completion, sponsored by Baylor Research Institute.
- TERMINATED
- Registry status
- 744 participants
- Enrollment target
Study Summary
The purpose of this registry is to evaluate information to determine which operations and treatments for gastroesophageal reflux disease or similar diseases of the stomach, esophagus or digestive tract are providing the most benefit including the long-term effects of treatment (or no treatment) and the progression of the disease over time.
Primary Outcome
Patient reported signs and symptoms as reported in Reflux scale and GERD questionnaire.
Interventions
- OTHER Diagnosed with GERD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 744 participants |
| Start Date | 2014-01 |
| Est. Completion | 2024-09 |
Why NCT02479438 stopped before completion
NCT02479438 is an observational study that tracks outcomes without assigning an intervention. The registered 744 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Diagnosed with GERD is the first listed.
NCT02479438 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02479438 about?
NCT02479438 is a clinical study titled "Gastroesophageal Reflux Disease Prospective Registry". The purpose of this registry is to evaluate information to determine which operations and treatments for gastroesophageal reflux disease or similar diseases of the stomach, esophagus or digestive tract are providing the most benefit including the long-term effects of treatment (or no treatment) and ...
What is the current status of trial NCT02479438?
This trial is currently terminated. The enrollment target is 744 participants. The study started on 2014-01. Estimated completion is 2024-09.
What interventions are being tested in trial NCT02479438?
The interventions under investigation include: Diagnosed with GERD (OTHER).
Who is sponsoring clinical trial NCT02479438?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05619185 · 744 participants · NA
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
- NCT06417814 · 744 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT07046351 · 744 participants · NA
weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents
- NCT07199569 · 744 participants · Phase 2
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia